Tesamorelin (Egrifta SV) is approved to reduce excess abdominal fat in HIV-associated lipodystrophy and has formal prescribing information, warnings, and monitoring expectations
Our investigation into digestive enzyme supplements began by examining how these enzymes function in the body and where supplementation can make a meaningful difference
Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N
The provider should ask about weight history, diabetes history, cardiovascular history, kidney concerns, digestive symptoms, thyroid history, prior weight-loss attempts, pregnancy plans (where relevant), and current medications
A more aggressive approach would be to require a routine step through SGLT2s or DPP-4s to access GLP-1s, which clinicians on the panel said lacked clinical nuance